Unknown

Dataset Information

0

Gene therapy for retinitis pigmentosa.

ABSTRACT: Rhodopsin-mediated autosomal dominant retinitis pigmentosa (RP) is the most common cause of RP in North America. There is no proven cure for the disease, and multiple approaches are being studied. Gene therapy is an evolving field in medicine and ophthalmology. In this review, we will go over the basic concept of gene therapy and the different types of gene therapy that are currently being studied to treat this disease.

SUBMITTER: Piri N 

PROVIDER: S-EPMC8757518 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Advances in gene therapy technologies to treat retinitis pigmentosa.
| S-EPMC3878960 | biostudies-literature
Unknown Gene Therapy for Rhodopsin-associated Autosomal Dominant Retinitis Pigmentosa.
| S-EPMC8478325 | biostudies-literature
Unknown Gene therapy for the treatment of X-linked retinitis pigmentosa.
| S-EPMC6059358 | biostudies-literature
Unknown Gene Therapy in a Large Animal Model of PDE6A-Retinitis Pigmentosa.
| S-EPMC5476745 | biostudies-literature
Unknown Long-term RNA interference gene therapy in a dominant retinitis pigmentosa mouse model.
| S-EPMC3215008 | biostudies-other
Unknown Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa.
| S-EPMC7545001 | biostudies-literature
Unknown Optimization of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Due to RPGR Mutations.
| S-EPMC5542804 | biostudies-literature
Unknown CNTF Gene Therapy Confers Lifelong Neuroprotection in a Mouse Model of Human Retinitis Pigmentosa.
| S-EPMC4539573 | biostudies-literature
Unknown Recent advances of stem cell therapy for retinitis pigmentosa.
| S-EPMC4159862 | biostudies-literature
Unknown A novel mutation in retinitis pigmentosa GTPase regulator gene with a distinctive retinitis pigmentosa phenotype in a Chinese family.
| S-EPMC2927444 | biostudies-literature